Evidence map›Paper›PMID 25104802›Full record

ArticleJournal of the American Society of Nephrology : JASN2014

A nomogram for the prediction of kidney stone recurrence.

Brian H Eisner, David S Goldfarb

Registry-linked trialAbstract readEditorialComment
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05452291 (Exploring Multiomics Biomarkers for Urolithiasis), which is not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05452291 recruitingnot on this mapstarted 2022, after this paper: background citation

Exploring Multiomics Biomarkers for Urolithiasis

TypeobservationalSponsorChinese University of Hong KongRan2022 to 2027Enrolled1,200ConditionsUrolithiasis
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Impact of body mass index on size and composition of urinary stones: a systematic review and meta-analysis.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. M2 Macrophages Attenuate AQP2Research (Washington, D.C.) · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Brian H EisnerDepartment of Urology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; and beisner@partners.org.
David S GoldfarbNew York Harbor Veterans Affairs Healthcare System and New York University School of Medicine, New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NomogramsFemaleHumansKidney CalculiMalenomogramstone diseasestone recurrence

Identifiers

PMID25104802
PMCPMC4243365

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.